36th Annual Meeting and Exposition
of the Controlled Release Society
July 18-22, 2009
Bella Center
Copenhagen, Denmark

Innovation in Discovery, Diagnostics, and Delivery

CRS Scientific Secretary

Ijeoma Uchegbu, University of London, U.K.

Bioactive Materials Program Chairs

Paolo Ferruti, University of Milan, Italy

Paul Gellert, AstraZeneca, U.K.

Tamara Minko, Rutgers University, U.S.A.

Consumer & Diversified Products Program Chairs

Claudio Ortiz, Colgate Palmolive, U.S.A.

Birgit Schleifenbaum, Firmenich SA, Switzerland

Veterinary Program Chairs

Raid Alany, University of Auckland, New Zealand

Cyril Desevaux, Novartis Animal Health, Switzerland

Featured Plenary Speakers:

Gary Cleary, Corium International, Inc., U.S.A.
The Emergence of Innovative Transdermal-based Delivery Systems

Heico Frima, European Commission, Belgium
Nanomedicine Research in the EU 7th Framework Program for RTD

Silvio Garattini, Mario Negri Institute for Pharmacological Research, Italy
What is Needed to Further Improve the Health in the World?

Allan Hoffman,University of Washington, U.S.A.
The Early History and Evolution of the Controlled Drug Delivery Field

Robert Kiss, Belgian National Fund of Scientific Research, Belgium
Targeting the Na+-ATPhase to Combat Metastatic and/or Multidrug-Resistant Cancers

R.K. Pachauri, Chairman of the Intergovernmental Panel on Climate Change, 2007 Nobel Peace Prize Winner, India

Mini-symposia Topics and Invited Speakers:

AIDS – Back to Basics

Mario Clerici, Milano University, Italy, New Concepts in the Immunopathogenesis of HIV
Patrick Kiser, University of Utah, U.S.A., Delivery Systems Designed to Prevent HIV Transmission
Virendra Pandey, University of Medicine and Dentistry of New Jersey, U.S.A., Targeting Critical Regions of HIV-1 Genome for Intervention of HIV-1 Replication
Patrick Sinko, Rutgers University, U.S.A., Active Targeting OF HIV Sanctuary Sites Using Biodegradable Peptide-Based PEG Nanocarriers

Innovations in Drug Delivery for Animal and Human Health Applications

Elias Fattal,University of Paris-XI, France, Delivery Systems for the Removal of Colonic Residual Antibiotic to Reduce the Emergence of Resistances
Mathieu Peyrou, Novartis Animal Health, Switzerland, Innovative PK Approaches in the Development of Controlled Release Veterinary Drugs
Michael Roberts, University of Queensland, Australia, Enhancement Strategies in Skin Penetration of Solutes and Nanoparticles: Species Differences
Thierry Vandamme, University of Strasbourg, France, Drug Delivery Systems Developed for Animal Health Applications

Malaria, 1 Million Deaths a Year and Still Counting!

Ann Grobler, North-West University, South Africa
Song Jian-Ping, Guangzhou University of Chinese Medicine, China
Solomon Nwaka, World Health Organization, Switzerland
Richard Haynes, Hong Kong University, China, Artemisins-Marvellous Antimalrian Drugs-Advantages and Shortcomings

Neurodegeneration – Stopping the Clock

Christian Czech, F. Hoffmann-LaRoche, Switzerland, Disease Modification and New Biomarkers for Alzheimer’s Disease
Paul Gellert, AstraZeneca, U.K., Linking Disease and Delivery
John Hardy, National Institutes of Health, U.S.A., Fundamental Biology: New Therapeutic Opportunities
Samuel Svensson, AstraZeneca, Sweden

Translational Medicine–From the Lab to the Patient

Ruth Duncan, Cardiff University, U.K.
Jeff Evans, University of Glasgow Cancer Research, Scotland, Anti-Cancer Drug Development: Promises and Pitfalls
Tim Higenbottam, Chiesi Farmaceutici SpA, Italy
Alberto Gabizon, Shaare Zedek MC, Israel, Liposome Applications in Cancer Therapy-Doing New Tricks to Old Drugs
Jindrich (Henry) Kopecek, University of Utah, U.S.A., Polymeric Nanomedicines: Current Status and Future Prospects

Scientific Session Topics and Invited Speakers:

Advances in Process Technology

Bojana Boh, University of Ljubljana, Slovenia, Research and Innovation Trends in Microencapsulation

Biomaterials for Medicines

Nicola Tirelli, University of Manchester, U.K.

Blood Brain Barrier

Joerg Kreuter, University of Frankfurt, Germany, Nanoparticles as a Tool for Overcoming the Blood Brain Barrier

Characterization Techniques-New Approaches

Mike Reading, University of East Anglia, U.K., New Thermal and Photothermal Techniques for Pharmaceutical Materials Characterization

Controlled Release for Textiles

Raymond Mathis, Cognis GmbH, Germany, Delivery of Micro-encapsulated Cosmetic Ingredients from Textiles to the Skin

Evaluation of Controlled Release Products

Andreas Degenhardt, Symrise, Germany, Benchmarking Methods of Particles

Future Directions for Controlled Release

Igor Bodnar, NIZO, The Netherlands

Gene Therapy

Chun Wang, University of Minnesota, U.S.A., Engineering Polymers for DNA Vaccine Delivery

Imaging Technologies for Diagnostics and Treatment

Zheng-Rong Lu, University of Utah, U.S.A., Contrast Enhanced MRI in Drug Development

Inhaled Medicines

Thomas Kissel, Philipps University, Germany, Nano-Carriers for Pulmonary Drug and Gene Delivery
Tamara Minko, Rutgers University, U.S.A., Inhalatory Co-delivery of Anticancer Drugs and Antisense Oligonculeotides/siRNA for Lung Cancer Treatment

Inorganic Nanoparticles

Giovanni Baldi, Colorobbia, Italy, Nano Theranostic: Magnetic Nanoparticles for Cancer Diagnosis and Therapy

Leading Edge Device Technologies

Orest Lastow, AstraZeneca, Sweden, How Should the Next Generation Inhalation Device Address the Patient Needs of the Future?
Robert Levy, Children’s Hospital of Philadelphia, U.S.A., Gene Delivery Stents: Strategies for Variable Dosing and Sustained Transgene Expression

Liposomes and Micelles

Vladimir Torchilin, Northeastern University, U.S.A., Liposomes and Polymeric Micelles as Pharmaceutical Carriers: New Horizons

Membrane Transporters–Crossing Biological Barriers

Mark Gumbleton, Cardiff University, U.K.

Micro and Nano Particles

Jens Uhlemann, Bayer, Germany, Options and Applications for Nanoscale Delivery Systems

Nanomedicines

Hamid Ghandehari, University of Utah, U.S.A., Nanoconstructs for Controlled Delivery: Towards a Higher Degree of Definition

Nanotechnology and Animal Models: Improving Health Outcomes - an Animal Health/Veterinary and Bioactive Materials joint session

Patrick Couvreur, University of Paris-XI, France, Squalenoylation: A Platform for the Discovery of New Anticancer and Antiviral Nanomedicines
Jean-Christophe Leroux, University of Zurich, Switzerland, Evaluation of Gliadin/Polymer Nanocomplexes in a Mouse Model of Gluten Sensitivity

Nasal Drug Delivery

Erik Bjork, University of Uppsala, Sweden

New Candidates for Polymer Therapeutics

Paolo Ferruti, University of Milan, Italy
Etienne Schacht, University of Ghent, Belgium

New Materials for Nanotechnology

Dennis Discher, University of Pennsylvania, U.S.A.

Oral Controlled Release Technologies

Paolo Colombo, University of Parma, Italy, Drug Delivery Modules and Assemblage Technology for Combined Product Development
Abraham Rubinstein, Hebrew University of Jerusalem, Israel, Targeting GI Mucosal Diseases via the Oral Route: Design Strategies

Oral Delivery-Improving Absorption

Paul Dickinson, AstraZeneca, U.K.
Ijeoma Uchegbu, University of London, U.K., Shuttling Drug Molecules Across the Gut Ephithelium: From the Molecule to the Medicine

PEG Based-Systems: Modulating Pharmacokinetics with Polymers

Paolo Caliceti, University of Padova, Italy, PEGnology: State of the Art and Perspectives

Peptide and Protein Medicines

Simon Richardson, University of Greenwich, U.K., Copying Nature in Order to Safely Deliver Macromolecules to the Cytosol: The Use of Polymers and Recombinant Proteins

siRNA Therapy

David Rozema, Mirus Bio Corporation/University of Wisconsin, U.S.A., Dynamic PolyConjugates: A Rationally Designed, Modular Platform for Systemic siRNA Delivery

Stents

Clive Roberts, University of Nottingham, U.K.

Tissue Engineering

Ann-Christine Albertsson, University of Sweden, Sweden, Towards an Ideal Polymer Scaffold for Bone Tissue Engineering

Transdermal

Diane Burgess, University of Connecticut, U.S.A., Nanotechnology Approaches in Transdermal Drug Delivery

Tumor Targeting

Kazunori Kataoka, University of Tokyo, Japan, Smart Supramolecular Nanodevices for Tumor Targeting

Uniquely Original Delivery Systems

Gleb Sukhorukov, Queen Mary University, U.K.

Vaccines

David Putnam, Cornell University, U.S.A., Delivery of Foreign Antigens by Engineered Outer Membrane Vesicle Vaccines

All speakers, topics, and titles are subject to change.